For traders with a bullish short-term outlook on the U.S. cannabis sector, the AdvisorShares MSOS Daily Leveraged ETF (NYSEARCA: MSOX) provides a specialised instrument designed to amplify daily upside movements in U.S. cannabis equities. MSOX is a leveraged ETF that seeks to deliver enhanced daily exposure to the AdvisorShares Pure US Cannabis ETF (MSOS), which tracks leading U.S. multi-state operators and cannabis-related companies. As with all leveraged products, effective use of MSOX requires a clear understanding of its daily reset mechanism, short holding horizon, and the impact of compounding on returns beyond a single trading session.

Leveraged Exposure to a Policy- and Catalyst-Driven Sector
The U.S. cannabis industry is highly sensitive to regulatory developments, legislative progress, earnings updates, capital market access, and shifts in investor risk appetite. Price movements can be sharp and event-driven, particularly around developments such as federal rescheduling discussions, SAFE Banking Act progress, state-level legalization initiatives, or quarterly results from major multi-state operators. In this environment, leveraged ETFs like MSOX allow traders to express high-conviction, tactical bullish views with magnified sensitivity to daily price movements across the sector rather than to a single stock.
MSOX is structured to deliver, before fees and expenses, approximately two times (+2x) the daily performance of MSOS. In practical terms:
Because leverage is reset daily, MSOX’s performance over periods longer than one day may diverge materially from simply twice the cumulative return of MSOS, particularly in volatile or range-bound markets.
Who Should Consider MSOX?
The AdvisorShares MSOS Daily Leveraged ETF is intended for active, sophisticated traders who are comfortable managing leveraged exposures and monitoring positions closely. It is not designed for long-term investors or buy-and-hold strategies.
Common tactical use cases include:
Due to daily reset and compounding effects, MSOX requires active oversight, as multi-day holding periods can lead to outcomes that differ significantly from the expected +2x cumulative performance of MSOS.
Key Risks and Strategic Considerations
Before trading MSOX, investors should carefully evaluate the following:
Price Chart & Technical Summary


Conclusion
MSOX is a precision trading instrument designed to provide amplified daily long exposure to the U.S. cannabis sector via MSOS. For experienced traders who understand leveraged ETF mechanics and the policy-driven volatility inherent in cannabis equities, MSOX can be an effective tool for expressing short-term bullish views. However, its daily reset structure, sensitivity to compounding, and exposure to a highly volatile sector necessitate disciplined position sizing, active monitoring, and a clear understanding of leveraged product behavior across varying market conditions.
This report (“Report”) has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any advice provided in this Report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred in this Report. You should obtain a copy of the relevant Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any of the general advice in this Report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its reports (including this Report), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations to invest in securities and other financial products. Kalkine is not responsible for, and does not guarantee, the performance of, or returns on, any investments mentioned in this Report.
Kalkine does not issue, sell or deal in any financial products.
This Report may contain information on past performance of particular investments. Past performance is not a reliable indicator of future performance. Returns stated do not take into account transaction costs and taxes. To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Report, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Report or on the Kalkine website. Any such employees and associates are required to comply with certain, procedures and disclosures as required by law.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this Report.
Copyright 2025 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this report, or its content, may be reproduced in any form without our prior consent.
Past performance is not a reliable indicator of future performance.